General Information of the Compound
Compound ID
CP0141788
Compound Name
(2S,5R)-5-Ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)-piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile
    Show/Hide
Synonyms
ABT-279
LS-193221
    Show/Hide
Structure
Formula
C21H25N5O3
Molecular Weight
395.463
Canonical SMILES
CC1(CCN(CC1)c1cc(ccn1)C(O)=O)NCC(=O)N1[C@H](CC[C@H]1C#N)C#C
    Show/Hide
InChI
InChI=1S/C21H25N5O3/c1-3-16-4-5-17(13-22)26(16)19(27)14-24-21(2)7-10-25(11-8-21)18-12-15(20(28)29)6-9-23-18/h1,6,9,12,16-17,24H,4-5,7-8,10-11,14H2,2H3,(H,28,29)/t16-,17-/m0/s1
    Show/Hide
InChIKey
FIMRNLAKAARHPD-IRXDYDNUSA-N
Physicochemical Property
logP
1.24468
Rotatable Bonds
5
Heavy Atom Count
29
Polar Areas
109.56
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
6
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16049769
ChEMBL ID
CHEMBL386369
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00907, Dipeptidyl peptidase 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000034 Caco-2 Homo sapiens (Human)  1
1
Ki = 1 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( ABT-279 )
Drug Name ABT-279
Company Abbott Lab
Indication
Type-2 diabetes
Discontinued in Phase 1
Target(s)
Dipeptidyl peptidase 4 (DPP-4)
Inhibitor